Organization
UCLA Ahmanson Translational Theranostics Division
3 abstracts
Abstract
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.Org: UCLA Department of Radiation Oncology, UCLA Department of Nuclear Medicine, UCLA Ahmanson Translational Theranostics Division, UCLA Department of Urology, UCLA Department of Medical Oncology,
Abstract
PSMA PET findings in an “EMBARK-like” cohort of patients with high-risk non-metastatic hormone-sensitive prostate cancer: A single center post-hoc retrospective analysis.Org: UCLA-Caltech Medical Scientist Training Program, UCLA Ahmanson Translational Theranostics Division, UCLA Department of Radiation Oncology, Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, University of California Irvine,
Abstract
Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter prospective phase 3 imaging trial.Org: UCLA Ahmanson Translational Theranostics Division, Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, UCLA Nuclear Medicine, Department of Radiology and Biomedical Imaging, University of California Irvine,